Viral Interference between Respiratory Viruses.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Author(s): Piret J; Boivin G
  • Source:
    Emerging infectious diseases [Emerg Infect Dis] 2022 Feb; Vol. 28 (2), pp. 273-281.
  • Publication Type:
    Journal Article; Review
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) Country of Publication: United States NLM ID: 9508155 Publication Model: Print Cited Medium: Internet ISSN: 1080-6059 (Electronic) Linking ISSN: 10806040 NLM ISO Abbreviation: Emerg Infect Dis Subsets: MEDLINE
    • Publication Information:
      Original Publication: Atlanta, GA : National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC), [1995-
    • Subject Terms:
      COVID-19* ; Respiratory Tract Infections*/epidemiology ; Viruses*; Animals ; Humans ; Pandemics ; SARS-CoV-2 ; Viral Interference
    • Abstract:
      Multiple respiratory viruses can concurrently or sequentially infect the respiratory tract and lead to virus‒virus interactions. Infection by a first virus could enhance or reduce infection and replication of a second virus, resulting in positive (additive or synergistic) or negative (antagonistic) interaction. The concept of viral interference has been demonstrated at the cellular, host, and population levels. The mechanisms involved in viral interference have been evaluated in differentiated airway epithelial cells and in animal models susceptible to the respiratory viruses of interest. A likely mechanism is the interferon response that could confer a temporary nonspecific immunity to the host. During the coronavirus disease pandemic, nonpharmacologic interventions have prevented the circulation of most respiratory viruses. Once the sanitary restrictions are lifted, circulation of seasonal respiratory viruses is expected to resume and will offer the opportunity to study their interactions, notably with severe acute respiratory syndrome coronavirus 2.
    • References:
      Euro Surveill. 2009 Oct 08;14(40):. (PMID: 19822124)
      Pediatr Int. 2005 Aug;47(4):412-6. (PMID: 16091079)
      J Infect Dis. 2015 Dec 1;212(11):1701-10. (PMID: 25943206)
      J Virol. 2018 Nov 12;92(23):. (PMID: 30232180)
      Med Microbiol Immunol. 2016 Jun;205(3):209-18. (PMID: 26582554)
      Euro Surveill. 2013 Jun 06;18(23):. (PMID: 23787130)
      J Infect Dis. 1985 Jan;151(1):81-8. (PMID: 3965596)
      PLoS Pathog. 2020 Jul 29;16(7):e1008737. (PMID: 32726355)
      J Infect Dis. 2018 Jan 30;217(4):548-559. (PMID: 29325138)
      Scand J Infect Dis. 2007;39(6-7):653-4. (PMID: 17577842)
      Clin Infect Dis. 2021 Jun 15;72(12):e978-e992. (PMID: 33216851)
      Prog Med Virol. 1989;36:191-202. (PMID: 2555836)
      Access Microbiol. 2019 Nov 4;2(1):acmi000075. (PMID: 33062934)
      J Infect Dis. 2013 May 1;207(9):1433-41. (PMID: 22829638)
      Lancet Microbe. 2020 Oct;1(6):e254-e262. (PMID: 33103132)
      J Infect Dis. 2021 Dec 1;224(11):1900-1906. (PMID: 34009376)
      Influenza Other Respir Viruses. 2012 May;6(3):e6-10. (PMID: 22212717)
      Viruses. 2021 Jan 19;13(1):. (PMID: 33478119)
      Influenza Other Respir Viruses. 2014 Jul;8(4):422-30. (PMID: 24698156)
      Front Immunol. 2018 Oct 24;9:2466. (PMID: 30405642)
      PLoS One. 2012;7(9):e45807. (PMID: 23029253)
      J Gen Virol. 2011 Sep;92(Pt 9):2122-2132. (PMID: 21632569)
      Euro Surveill. 2010 Feb 11;15(6):. (PMID: 20158981)
      Front Immunol. 2021 Aug 18;12:683002. (PMID: 34489934)
      J Virol. 2021 Jun 24;95(14):e0013021. (PMID: 33893170)
      Med Hypotheses. 2011 Dec;77(6):1132-4. (PMID: 21975051)
      Nat Med. 2020 May;26(5):676-680. (PMID: 32371934)
      Zh Mikrobiol Epidemiol Immunobiol. 1992;(11-12):37-40. (PMID: 1338742)
      Front Microbiol. 2021 Aug 31;12:626553. (PMID: 34531831)
      Infection. 2014 Apr;42(2):303-8. (PMID: 24150959)
      Epidemiol Infect. 2019 Jan;147:e221. (PMID: 31364539)
      J Exp Med. 2021 Aug 2;218(8):. (PMID: 34128960)
      Crit Rev Microbiol. 2020 Aug;46(4):420-432. (PMID: 32715811)
      J Virol. 2008 May;82(10):4834-43. (PMID: 18321971)
      J Innate Immun. 2020;12(1):4-20. (PMID: 31610541)
      Clin Microbiol Infect. 2010 Apr;16(4):326-9. (PMID: 20121829)
      J Infect Dis. 2018 Jul 2;218(3):406-417. (PMID: 29746640)
      Influenza Other Respir Viruses. 2011 Nov;5(6):375-9. (PMID: 21668684)
      J Infect Dis. 2021 Jul 2;224(1):31-38. (PMID: 33754149)
      Clin Microbiol Infect. 2016 Feb;22(2):208.e1-208.e6. (PMID: 26482269)
      J Clin Virol. 2009 May;45(1):10-5. (PMID: 19376742)
      Influenza Other Respir Viruses. 2016 Jan;10(1):14-26. (PMID: 26369646)
      Vaccine. 2011 Mar 24;29(15):2777-84. (PMID: 21320545)
      J Infect Dis. 2017 Apr 1;215(7):1102-1106. (PMID: 28368456)
      Acta Virol. 2000 Apr;44(2):91-7. (PMID: 10989700)
      PLoS One. 2021 May 6;16(5):e0251170. (PMID: 33956882)
      Annu Rev Immunol. 2014;32:513-45. (PMID: 24555472)
      Nat Microbiol. 2019 Jul;4(7):1075-1087. (PMID: 31160826)
      Proc Natl Acad Sci U S A. 2019 Dec 16;:. (PMID: 31843887)
      BMC Infect Dis. 2017 Dec 16;17(1):772. (PMID: 29246199)
    • Contributed Indexing:
      Keywords: COVID-19; SARS-CoV-2; coronavirus disease; human metapneumovirus; human rhinovirus; influenza virus; innate immunity; interferon; respiratory infections; respiratory syncytial virus; respiratory viruses; severe acute respiratory syndrome coronavirus 2; viral interference; viruses; zoonoses
    • Publication Date:
      Date Created: 20220125 Date Completed: 20220127 Latest Revision: 20220218
    • Publication Date:
      20221213
    • Accession Number:
      PMC8798701
    • Accession Number:
      10.3201/eid2802.211727
    • Accession Number:
      35075991